Catalyst Wire Dossier Catalyst Wire Dossier

Telotristat Ethyl

telotristat ethyl · Ipsen
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Telotristat Ethyl, covering 2018-04-25 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer [Phase 2]

See pricing